ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Akero Therapeutics Inc

Akero Therapeutics Inc (AKRO)

41.68
-0.44
(-1.04%)
Closed March 10 3:00PM
41.68
0.00
( 0.00% )
Pre Market: 5:15AM

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00000000
Operating Income -25.42M-28.75M-35.63M-46.62M-61.87M-59.95M-65.74M-81.7M
Pre Tax Income -23.06M-25.83M-31.08M-39.66M-55.19M-53.34M-55.99M-72.71M
Net Income -23.06M-25.83M-31.08M-39.66M-55.19M-53.34M-55.99M-72.71M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -25.42M-25.37M-30.23M-38.77M-61.87M-59.95M-65.74M-81.7M
EBITDA -25.41M-28.74M-35.62M-46.61M-61.87M-59.95M-65.74M-81.7M
Year End December 30 2023 2017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 0000000
Operating Income -4.56M-13.78M-45.65M-80.15M-100.89M-115.16M-172.87M
Pre Tax Income -4.56M-81.71M-43.76M-79.21M-100.78M-112.03M-151.76M
Net Income -4.78M-82.23M-43.76M-79.21M-100.78M-112.03M-151.76M
Preferred Dividends -213k-520k00000
Basic Earnings Per Share (EPS) -6.864-111.883-1.532-2.28-2.89-2.391-2.724
EBIT -4.56M-81.71M-45.65M-80.15M-100.89M-115.16M-172.87M
EBITDA -4.56M-13.78M-45.65M-80.14M-100.85M-115.11M-172.84M